Ocupress
Ocupress Brand names, Ocupress Analogs
Ocupress Brand Names Mixture
- No information avaliable
Ocupress Chemical_Formula
C16H24N2O3
Ocupress RX_link
http://www.rxlist.com/cgi/generic2/carteol.htm
Ocupress fda sheet
Ocupress msds (material safety sheet)
Ocupress Synthesis Reference
No information avaliable
Ocupress Molecular Weight
292.373 g/mol
Ocupress Melting Point
No information avaliable
Ocupress H2O Solubility
No information avaliable
Ocupress State
Solid
Ocupress LogP
2.037
Ocupress Dosage Forms
Ophthalmic Solution (1%)
Ocupress Indication
For the treatment of intraocular hypertension and chronic open-angle glaucoma
Ocupress Pharmacology
Carteolol is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity. Carteolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage. Carteolol reduces intraocular pressure with little or no effect on pupil size or accommodation in contrast to the miosis which cholinergic agents are known to produce.
Ocupress Absorption
No information avaliable
Ocupress side effects and Toxicity
The most common effects expected with overdosage of a beta-adrenergic blocking agent are bradycardia, bronchospasm, congestive heart failure and hypotension.
Ocupress Patient Information
No information avaliable
Ocupress Organisms Affected
Humans and other mammals
